Ikaros as a downstream mediator of BCR blockade therapy in B-cell non-Hodgkin lymphoma
Oncoscience
.
2022 Nov 28:9:64-65.
doi: 10.18632/oncoscience.568.
eCollection 2022.
Authors
Marcelo Lima Ribeiro
,
Emmanuel Normant
,
Gaël Roué
PMID:
36458104
PMCID:
PMC9708099
DOI:
10.18632/oncoscience.568
No abstract available
Keywords:
B-NHL; Bruton’s tyrosine kinase; Ikaros; combination therapies; phosphoproteomics.
Publication types
Editorial